Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Abivax (ABVX) Equity Average: 2024-2025

  • Abivax's Equity Average was N/A to $155.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was $155.5 million, marking a year-over-year change of. This contributed to the annual value of $285.6 million for FY2024, which is N/A change from last year.
  • According to the latest figures from Q2 2025, Abivax's Equity Average is $155.5 million, which was down 21.24% from $197.5 million recorded in Q1 2025.
  • Abivax's Equity Average's 5-year high stood at $262.8 million during Q4 2024, with a 5-year trough of $155.5 million in Q2 2025.
  • Its 2-year average for Equity Average is $205.3 million, with a median of $197.5 million in 2025.